NASDAQ · ASBPWHealthcarePharmaceuticals

Aspire-Lakewood Holdings, Inc. Warrant financials

$0.0133−32.83%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$6.2K
Gross profit-$116.00
Gross margin−1.9%
Operating income-$19.4M
Net income-$24.5M
Net margin−394725.1%
Diluted EPS$-491.40
EBITDA-$19.4M
Operating cash flow-$4.9M
Free cash flow-$4.9M
Diluted shares0.0M

Balance sheet

Period endDec 31
Cash & equivalents$1.0M
Short-term investments$0.00
Total debt$2.8M
Total assets$1.3M
Total liabilities$7.7M
Shareholders' equity-$6.4M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology